Copyright
©The Author(s) 2020.
World J Gastrointest Endosc. Nov 16, 2020; 12(11): 408-450
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Published online Nov 16, 2020. doi: 10.4253/wjge.v12.i11.408
Table 4 Endoscopic retrograde cholangiopancreatography (diagnostic)
| Ref. | Year | Country | Study design | n | Procedure | Medication | Relative risk |
| Masci et al[21] | 2001 | Italy | Prospective | 782 | ERCP (diagnostic) | No medications | Incidence of PPB 1.13% |
| Williams et al[22] | 2007 | United Kingdom | Prospective | 5264 | ERCP (diagnostic) | No medications | Incidence of PPB 0.9% |
| Cotton et al[23] | 2009 | United States | Retrospective | 11497 | ERCP (diagnostic) | No medications | Incidence of PPB 0.3% |
| Coelho-Prabhu et al[24] | 2013 | United States | Retrospective | 1072 | ERCP (diagnostic) | No medications | Incidence of PPB 1.4% |
| Rotundo et al[25] | 2020 | United States | Retrospective | 555 | ERCP (diagnostic) | No medications | Incidence of PPB 1.66% (teaching hospital). Incidence of PPB 1.49% (nonteaching hospital) |
- Citation: Chan A, Philpott H, Lim AH, Au M, Tee D, Harding D, Chinnaratha MA, George B, Singh R. Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence. World J Gastrointest Endosc 2020; 12(11): 408-450
- URL: https://www.wjgnet.com/1948-5190/full/v12/i11/408.htm
- DOI: https://dx.doi.org/10.4253/wjge.v12.i11.408